Guidance

Diphtheria, tetanus and inactivated poliomyelitis vaccine (Td/IPV - Revaxis®): patient group direction (PGD) template

PGD template to support the national diphtheria, tetanus and inactivated poliomyelitis (Td/IPV - Revaxis®) vaccination programme.

Documents

Diphtheria, tetanus and inactivated poliomyelitis vaccine (Td/IPV - Revaxis®): patient group direction (PGD) template

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template is to support the administration of diphtheria, tetanus and inactivated poliomyelitis vaccine (Td/IPV), to individuals from 10 years of age, in accordance with national recommendations and the routine childhood immunisation programme.

It is valid from 1 November 2017 to 31 October 2019.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy and procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Published 6 November 2015
Last updated 19 October 2017 + show all updates
  1. Reviewed and updated to add management of cases and contacts.
  2. First published.